Advances in drug delivery systems utilizing blood cells and their membrane-derived microvesicles
The advancement of drug delivery systems (DDSs) in recent decades has demonstrated significant potential in enhancing the efficacy of pharmacological agents. Despite the approval of certain DDSs for clinical use, challenges such as rapid clearance from circulation, toxic accumulation in the body, an...
Saved in:
| Main Authors: | Andong He, Yuye Huang, Chao Cao, Xuejin Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Drug Delivery |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/10717544.2024.2425156 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Low MT‐CO1 in Monocytes and Microvesicles Is Associated With Outcome in Patients With Coronary Artery Disease
by: Paul Holvoet, et al.
Published: (2016-12-01) -
Recent advances in cell membrane-based biomimetic delivery systems for Parkinson’s disease: Perspectives and challenges
by: Jasleen Kaur, et al.
Published: (2025-08-01) -
Assessment of the Anti-Inflammatory Effectiveness of Diclofenac Encapsulated in Chitosan-Coated Lipid Microvesicles in Rats
by: Ana-Maria Raluca Pauna, et al.
Published: (2025-05-01) -
Membrane-based biomimetic delivery systems for glioblastoma multiforme therapy
by: Lv Guangyao, et al.
Published: (2025-06-01) -
Experimental application results of mesenchymal stem cell microvesicles in the mouse model of acute renal failure
by: I. P. Ivanova, et al.
Published: (2023-06-01)